Comera Life Sciences Holdings, Inc. (CMRA)
Converts injectable drugs into under-the-skin versions using a proprietary technology platform.
$0.00+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-50.0%
The outlook
CMRA is trading at its 52-week low with minimal price movement today. The stock sits above both its 50- and 200-day moving averages, suggesting some near-term support, though analyst coverage appears thin. The StockGlow score of 48/100 reflects a neutral lean without clear bullish or bearish conviction.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$3,073
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—